Pharmaceutical Organization Selects Provantis Preclinical Software Suite for German R&D Center

International Pharmaceutical Organization Deploying Provantis to Support Growth in GLP Studies

CONSHOHOCKEN, PA - (BUSINESS WIRE) – December 1, 2015 - -Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that an international research-based pharmaceutical company  has purchased the Provantis® preclinical software solution suite to automate laboratory processes at its R&D Center in Germany.

The company specializes in Pain Relief Therapies and has a long track record of delivering innovative pain treatments and state-of-the-art technologies to patients. Its purchase of Provantis will deliver increased efficiencies in the collection, storage and reporting of preclinical data and will support its recent growth in GLP studies.

Key Facts

• Client  to deploy the Provantis General Toxicology & Pathology modules
• Provantis to replace existing manual processes
• Client to utilize the integrated Data Import module to seamlessly import data from a wide variety of sources
• Instem’s Rapid Deployment Method being deployed to facilitate quick implementation and a rapid  return on investment

Gregor Grant, Senior Vice President, Instem, commented “We are delighted to welcome another client to the ever-growing Provantis user community. This latest client is actually a small laboratory within a much larger, international organization and it is great to see them harness the power of Provantis.”

About Instem

Instem is a leading supplier of IT applications to the early development healthcare market delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making, leading to safer, more effective products.

Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.

Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in Japan and India.

Meeting clients at the intersection of investment & return™.

Press Contacts:

Instem

Julie Jones (UK HQ)
julie.jones@instem.com
Tel: +44 (0) 1785 825600